Wedbush Securities & UBS
5 shared events · Importance 5 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Wedbush Securities: Wedbush Securities is acting as a lead manager for the public offering by IDEAYA Biosciences, providing management support for the transaction.
UBS: UBS is acting as a joint book-running manager for the public offering by IDEAYA Biosciences, supporting the securities transaction.
Jun 08, 2026 · 9 articles
Business
Wedbush Securities: Wedbush Securities initiated coverage with a 'Buy' rating and a $270 target for Cerebras Systems, adding to the bullish outlook from Wall Street firms.
UBS: UBS initiated coverage with a 'Buy' rating and a $300 price target, highlighting Cerebras Systems as a 'fast inference pure play' with a growing backlog and performance advantage.
Jun 08, 2026 · 12 articles
Business
Wedbush Securities: Wedbush Securities analysts provided insights and predictions regarding a potential merger between SpaceX and Tesla, Inc.
UBS: UBS>>> is one of the international banks participating in the SpaceX>>> IPO, tasked with attracting wealthy individual investors.
Apr 20, 2026 · 457 articles
Business
Wedbush Securities: Wedbush Securities provided analysis on the potential impact of Quantinuum's IPO on the broader quantum computing sector, highlighting its significance for market discovery and coverage.
UBS: UBS acted as a joint-book running manager for Quantinuum's IPO.
May 26, 2026 · 76 articles
Business
Wedbush Securities: Wedbush initiated coverage on Cerebras Systems with an 'outperform' recommendation, impacting its stock price.
UBS: Analysts at UBS raised their 12-month price target for Micron Technology, contributing to the positive sentiment around the stock.
May 20, 2026 · 66 articles
NEWSDESK
Explore this relationship live
Track how Wedbush Securities and UBS interact across events, view sentiment trends, and discover connected entities.
Open Dashboard